Latest News

This AI darling is seeing its massive gains unwind amid the market volatility.

China's e-commerce powerhouse appears to have finally let go of what was holding it back from entering a new era.

Stocks got slaughtered this week in the wake of Trump's Liberation Day tariffs. The S&P is now off more than -15% from its all-time high earlier this year.

Year to date all Mag 7 stocks are performing worse than the market average. Although Meta and Microsoft are hanging pretty close.

The AUD/USD pair has crashed to the lowest level in over five years.

The past week saw major developments in the auto industry, including Tesla's anticipated Q1 delivery figures.

The mostly forgotten former technology titan may quietly be sitting on the next big thing in AI's ongoing evolution.

In favor of a potential upward reversal we are technically very oversold right now, but we also have to acknowledge this is a rather crazy news-driven market prone to severe whipsaws.

Contrary to expectations, interest rates are moving decisively lower.

The S&P 500 is still 1,140 points higher than the corresponding long-term trend value of 3,934 for April 2025.

If CAP-1002 (Deramiocel) is approved on schedule, deramiocel would become the first therapy indicated specifically for DMD-associated cardiomyopathy, addressing a critical unmet need. The StealthX(tm) exosome delivery system is a momentous change.